The role of transforming growth factor-β in the regulation of estrogen receptor expression in the MCF-7 breast cancer cell line

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1498-1505

  Stoica, Adriana ^a   Saceda, Miguel ^a   Fakhro, Amina ^a   Solomon, Harrison B ^a   Fenster, Bradley D ^a   Martin, Mary Beth ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; ESTRADIOL; ESTROGEN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BINDING SITE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DISSOCIATION CONSTANT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SCATCHARD PLOT;

EID: 0030938647     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5074     Document Type: Article

References (48)

1. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB 1987 Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428
2. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA 1993 Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992-998
3. Davis RJ 1993 The mitogen-activated protein kinase signal transduction pathways, J Biol Chem 268:14553-14556
4. Zajchowoski D, Band V, Pauzid N, Iager A, Stampfer M, Sager R 1988 Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. Cancer Res 48:7041-7047
5. Bates SE, McManaway ME, Lippman ME, Dickson RB 1986 Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res 46:1707-1713
6. Valverius EM, Walker-Jones D, Bates SE, Stampfer MR, McCormick F, Dickson RB, Lippman ME 1989 Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. Cancer Res 49:6269-6274
7. Cairus J 1975 Mutation selection and the natural history of cancer. Nature 255:197-200
8. Hong WK, Lippman ME, Itri LM, Karp DD, Leer JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ 1990 Prevention of second primary tumors with isoretinoids in squamous cell carcinoma of the head and neck. N Engl J Med 323:795-801
9. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK 1988 Transforming growth factor beta: potential autocrine growth factor inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48:3898-3904
10. King RJ, Wang DY, Daly RJ, Darbre PD 1989 Approaches to studying the role of growth factors in the progression of breast tumors from the steroid sensitive to insensitive state. J Steroid Biochem 34:133-138
11. Dickson RB, Kasid A, Huff KK, Bates SE, Knabbe C, Bronzert D, Gelman EP, Lippman ME 1987 Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci USA 84:837-841
12. Daly RJ, King RJB, Darbre PD 1990 Interaction of growth factors during the progression towards steroid independence in T-47-D human breast cancer cells. J Cell Biochem 43:199-211
13. Welch DR, Fabra A, Nakajima M 1990 Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87:7678-7682
14. Roberts AB, Sporn MB (eds) 1990 Peptide Growth Factors and Their Receptors: Handbook tor Experimental Pharmacology. Springer Verlag, Heidelberg, pp 410-472
15. Boyd FT, Massague J 1989 TGFβ inhibition of epithelial cell proliferation linked to the expression of a 53 kDa membrane receptor. J Biol Chem 264:2272-2278
16. Chen R-H, Ebner R, Derynck R 1993 Cloning of a type I TGFβ receptor and its effect on TGFβ binding to the type II receptor. Science 260:1335-1338
17. Kimchi A, Wang XF, Weinberg RA, Cheifetz S, Massague J 1988 Absence of TGFβ receptors and growth inhibitory responses in retinoblastoma cells. Science 240:196-199
18. Lopez-Casillas F, Wrana JL, Massague J 1993 Beaglycan presents ligand to the TGFβ signalling receptor. Cell 73:1435-1444
19. Massague J 1992 Receptors for the TGFβ family. Cell 69:1067-1070
20. Ebner R, Chen R-H, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynk R 1993 Inactivation of the type II receptor reveals two receptor pathways for the diverse TGFβ activities. Science 260:1344-1348
21. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J 1992 TGFβ signals through a heterometric protein kinase receptor complex. Cell 71:1003-1014
22. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS 1986 Phenol red in tissue culture is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496-2500
23. Darbre P, Yates J, Curtis S, King RJB 1983 Effect of estradiol on human breast cancer cells in culture. Cancer Res 43:349-354
24. Saceda M, Lippman ME, Chambon P, Lindsey RK, Puente M, Martin MB 1988 Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2:1157-1162
25. Masiakowski P, Breathnach R, Bloch J, Cannon F, Krust A, Chambon P 1982 Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line. Nucleic Acids Res 10:7895-7903
26. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptors forms A and B. EMBO J 9:1603-1614
27. Collier IE, Smith J, Kronberger A, Bauer EA, Wilhelm SM, Eisen AZ, Goldberg GI 1988 The structure of the human skin fibroblast collagenase gene. J Biol Chem 263:10711-10713
28. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM 1988 Induction of proto-oncogene JUN/AP1 by serum and TPA. Nature 334:629-631
29. Scatchard G 1949 The attractions of protein for small molecules and ions. Ann NY Acad Sci 51:660-672
30. Laborda J 1991 36B4 cDNA used as an estradiol-independent messenger RNA control is the cDNA for human acidic ribosomal phosphoprotein P0. Nucleic Acids Res 19:3998
31. Saceda M, Knabbe C, Dickson RB, Lippman ME, Bronzert D, Lindsey RK, Gottardis MM, Martin MB 1991 Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem 266:17809-17814
32. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B 1988 A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 52:405-414
33. Chen C, Okayama H1987 High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752
34. Read LD, Greene GL, Katzenellenbogen BS 1989 Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists and growth factors. Mol Endocrinol 3:295-304
35. 3 Endocrinology 133:553-562
36. Horwitz KB, McGuire WL 1978 Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem 253:2223-2228
37. Dickson RB, Lippman ME 1987 Estrogenic regulation of growth and polypeptide growth factor secretion in human carcinoma. Endocr Rev 8:29-43
38. Ritzenthaler JD, Goldstein RH, Fine A, Smith BD 1993 Regulation of the alpha 1 (I) collagen promoter via a transforming growth factor-beta activation element. J Biol Chem 268:13625-13631
39. King SL, Lichter AC, Rowe DW, Xie R, Long GL, Absher MP, Cutroneo KR 1994 Bleomycin stimulates pro-alpha I (I) collagen promoter through transforming growth factor-beta response element by intracellular and extracellular signaling. J Biol Chem 269:13156-13161
40. Shibanuma M, Kuroki T, Nose K 1992 Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor-beta 1 and other growth factors. J Biol Chem 267:10219-10224
41. Kerr LD, Miller DB, Matrisian LM 1990 TGFβ 1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 61:267-278
42. Mango V, Volpin D, Vitale G, Bressen GM 1994 Identification of a TGFβ responisive element in the human elastin promoter. Biochem Biophy Res Commun 199:1049-1056
43. Angel P, Baumann I, Stein B, Delius H, Rahrusdorf HJ, Herrlich P 1987 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 7:2256-2266
44. Hershey JWB 1989 Protein phosphorylation controls translation rates. J Biol Chem 264:20823-20826
45. Valette A, Gas N, Jozan S, Roubinit F, Dupont MA, Bayard F 1987 Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer Res 47:1615-1620
46. Guilbaud N, Pichon MF, Faye JC, Bayard F, Valette A 1988 Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell line. Mol Cell Endocrinol 56:157-163
47. Martin MB, Garcia-Morales P, Stoica A, Solomon HB, Katz D, Zhang S, Danielson M, Saceda M 1995 Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells. J Biol Chem 270:25244-25251
48. Saceda M, Grunt TW, Colomer R, Lippman ME, Lupu R, Martin MB 1996 Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines. Endocrinology 137:4322-4330